Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Assessment and support of people experiencing problematic substance use at the end of life

AI Summary
  • Rising need for end of life care for people with problematic substance use, driven by ageing opiate users and increased alcohol-related liver disease mortality.
  • Ensure accurate assessment and screening, and openly communicate to explore substance use, identify comorbidities such as kidney, respiratory conditions and chronic pain.
  • Advance care planning and tailored palliative care, including complex pain management, are challenging but essential for effective end of life support for this population.
Summarise with AI (MRCPsych/FRANZCP)

Nurs Stand. 2026 Jul 27. doi: 10.7748/ns.2026.e12715. Online ahead of print.

ABSTRACT

There is limited evidence relating to end of life care for people with a history of problematic substance use, despite a growing need for treatment related to an older opiate-using population and increased premature mortality associated with alcohol-related liver disease. This article examines several significant challenges for nurses in supporting people who have engaged in problematic substance use, often resulting in comorbidities such as kidney damage, respiratory conditions and/or chronic pain. These challenges include ensuring accurate assessment and screening and how to openly communicate with individuals to explore their problematic substance use. The author also discusses advance care planning at the end of life and the challenges of providing effective palliative care and pain management for this population.

PMID:42504127 | DOI:10.7748/ns.2026.e12715

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review
← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD